These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18611279)

  • 1. Antimalarial drug use in general populations of tropical Africa.
    Gardella F; Assi S; Simon F; Bogreau H; Eggelte T; Ba F; Foumane V; Henry MC; Kientega PT; Basco L; Trape JF; Lalou R; Martelloni M; Desbordes M; Baragatti M; Briolant S; Almeras L; Pradines B; Fusai T; Rogier C
    Malar J; 2008 Jul; 7():124. PubMed ID: 18611279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chloroquine and sulphadoxine-pyrimethamine efficacy for uncomplicated malaria treatment and haematological recovery in children in Bobo-Dioulasso, Burkina Faso during a 3-year period 1998-2000.
    Tinto H; Zoungrana EB; Coulibaly SO; Ouedraogo JB; Traoré M; Guiguemde TR; Van Marck E; D'Alessandro U
    Trop Med Int Health; 2002 Nov; 7(11):925-30. PubMed ID: 12390597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensity of malaria transmission, antimalarial-drug use and resistance in Uganda: what is the relationship between these three factors?
    Talisuna AO; Langi P; Bakyaita N; Egwang T; Mutabingwa TK; Watkins W; Van Marck E; D'Alessandro U
    Trans R Soc Trop Med Hyg; 2002; 96(3):310-7. PubMed ID: 12174786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.
    Kateera F; Nsobya SL; Tukwasibwe S; Hakizimana E; Mutesa L; Mens PF; Grobusch MP; van Vugt M; Kumar N
    Acta Trop; 2016 Dec; 164():329-336. PubMed ID: 27647575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid dissemination of Plasmodium falciparum drug resistance despite strictly controlled antimalarial use.
    Noranate N; Durand R; Tall A; Marrama L; Spiegel A; Sokhna C; Pradines B; Cojean S; Guillotte M; Bischoff E; Ekala MT; Bouchier C; Fandeur T; Ariey F; Patarapotikul J; Le Bras J; Trape JF; Rogier C; Mercereau-Puijalon O
    PLoS One; 2007 Jan; 2(1):e139. PubMed ID: 17206274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of therapeutic response of Plasmodium falciparum to chloroquine and sulfadoxine-pyrimethamine in an area of low malaria transmission in Colombia.
    Osorio LE; Giraldo LE; Grajales LF; Arriaga AL; Andrade AL; Ruebush TK; Barat LM
    Am J Trop Med Hyg; 1999 Dec; 61(6):968-72. PubMed ID: 10674680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmodium falciparum gametocytaemia in Nigerian children: before, during and after treatment with antimalarial drugs.
    Sowunmi A; Fateye BA
    Trop Med Int Health; 2003 Sep; 8(9):783-92. PubMed ID: 12950664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity to antimalarial drugs by Plasmodium falciparum in Goundry, Oubritenga province, Burkina Faso.
    Del Nero L; Lamizana L; Pietra V; Nebié I
    Parassitologia; 1994 Dec; 36(3):287-93. PubMed ID: 7637999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of chloroquine, amodiaquine and pyrimethamine-sulphadoxine in Gambian children with uncomplicated malaria.
    Müller O; van Hensbroek MB; Jaffar S; Drakeley C; Okorie C; Joof D; Pinder M; Greenwood B
    Trop Med Int Health; 1996 Feb; 1(1):124-32. PubMed ID: 8673817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of chloroquine and sulphadoxine-pyrimethamine either alone or in combination before introduction of ACT as first-line therapy in uncomplicated Plasmodium falciparum malaria in Jalpaiguri District, West Bengal, India.
    Mullick S; Das S; Guha SK; Bera DK; Sengupta S; Roy D; Saha P; Biswas A; Das M; Ray K; Kundu PK; Maji AK
    Trop Med Int Health; 2011 Aug; 16(8):929-35. PubMed ID: 21564429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early suppression of B cell immune responses by low doses of chloroquine and pyrimethamine: implications for studying immunity in malaria.
    Joseph H; Eriksson E; Schofield L
    Parasitol Res; 2019 Jun; 118(6):1987-1992. PubMed ID: 31069535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Limits of the efficacy of chloroquine and sulfadoxine-pyrimethamine in Northern Abidjan (Cote d'Ivoire): Combined in vivo and in vitro studies].
    Djaman J; Abouanou S; Basco L; Koné M
    Sante; 2004; 14(4):205-9. PubMed ID: 15745869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Change of antimalarial first-line treatment in Burkina Faso in 2005].
    Gansané A; Nébié I; Soulama I; Tiono A; Diarra A; Konaté AT; Ouédraogo A; Sirima BS
    Bull Soc Pathol Exot; 2009 Feb; 102(1):31-5. PubMed ID: 19343918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of chloroquine (CQ) and sulphadoxine/pyrimethamine (SP) therapy in uncomplicated falciparum malaria in Indo-Myanmar border areas.
    Mohapatra PK; Prakash A; Taison K; Negmu K; Gohain AC; Namchoom NS; Wange D; Bhattacharyya DR; Goswami BK; Borgohain BK; Mahanta J
    Trop Med Int Health; 2005 May; 10(5):478-83. PubMed ID: 15860095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of chloroquine, sulfadoxine-pyrimethamine and a combination of both for the treatment of uncomplicated Plasmodium falciparum malaria in an area of low transmission in western Uganda.
    Ndyomugyenyi R; Magnussen P; Clarke S
    Trop Med Int Health; 2004 Jan; 9(1):47-52. PubMed ID: 14728606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. History and importance of antimalarial drug resistance.
    D'Alessandro U; Buttiëns H
    Trop Med Int Health; 2001 Nov; 6(11):845-8. PubMed ID: 11703837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The drug sensitivity and transmission dynamics of human malaria on Nias Island, North Sumatra, Indonesia.
    Fryauff DJ; Leksana B; Masbar S; Wiady I; Sismadi P; Susanti AI; Nagesha HS; Syafruddin ; Atmosoedjono S; Bangs MJ; Baird JK
    Ann Trop Med Parasitol; 2002 Jul; 96(5):447-62. PubMed ID: 12194705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.
    Genton B; Baea K; Lorry K; Ginny M; Wines B; Alpers MP
    P N G Med J; 2005; 48(3-4):141-50. PubMed ID: 17212060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gametocytemia and infectivity to mosquitoes of patients with uncomplicated Plasmodium falciparum malaria attacks treated with chloroquine or sulfadoxine plus pyrimethamine.
    Robert V; Awono-Ambene HP; Le Hesran JY; Trape JF
    Am J Trop Med Hyg; 2000 Feb; 62(2):210-6. PubMed ID: 10813475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chloroquine resistant Plasmodium falciparum in indigenous residents of Cameroon.
    Oduola AM; Moyou-Somo RS; Kyle DE; Martin SK; Gerena L; Milhous WK
    Trans R Soc Trop Med Hyg; 1989; 83(3):308-10. PubMed ID: 2694461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.